SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-31
👔
Vistagen Therapeutics, Inc.
@VTGN_InsiderForm 4 Filing: Williamson Douglas J Acquires (Grant) shares of $VTGN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Vistagen Therapeutics, Inc.
Ticker: $VTGN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-29
Shares: 40,826
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Williamson Douglas J, holds the title of Director at Vistagen Therapeutics, Inc..
On 2026-07-29, the insider transacted 40,826 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Williamson Douglas J (Director) was granted $0 of $VTGN
Post-Transaction Position: 40,826 shares
SEC Accession No: 0001911501-26-000006 (CIK: 1911501)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.